Demyelinating Autoimmune Diseases, CNS
"Demyelinating Autoimmune Diseases, CNS" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Conditions characterized by loss or dysfunction of myelin (see MYELIN SHEATH) in the brain, spinal cord, or optic nerves secondary to autoimmune mediated processes. This may take the form of a humoral or cellular immune response directed toward myelin or OLIGODENDROGLIA associated autoantigens.
MeSH Number(s)
C10.114.375
C10.228.140.695.562
C10.228.518.562
C10.314.350
C20.111.258.250
Concept/Terms
Demyelinating Autoimmune Diseases, CNS- Demyelinating Autoimmune Diseases, CNS
- Demyelinating Autoimmune Disorders, CNS
- Demyelinating Disease, Autoimmune, CNS
- CNS Demyelinating Autoimmune Diseases
- Autoimmune Demyelinating Diseases, CNS
- Autoimmune Demyelinating Disorders, CNS
- CNS Autoimmune Demyelinating Disorders
- Demyelinating Autoimmune Diseases, Central Nervous System
- Autoimmune Demyelinating Diseases, Central Nervous System
Below are MeSH descriptors whose meaning is more general than "Demyelinating Autoimmune Diseases, CNS".
Below are MeSH descriptors whose meaning is more specific than "Demyelinating Autoimmune Diseases, CNS".
This graph shows the total number of publications written about "Demyelinating Autoimmune Diseases, CNS" by people in Harvard Catalyst Profiles by year, and whether "Demyelinating Autoimmune Diseases, CNS" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2015 | 1 | 1 | 2 |
| 2016 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
| 2020 | 3 | 0 | 3 |
| 2021 | 2 | 0 | 2 |
| 2022 | 1 | 0 | 1 |
Below are the most recent publications written about "Demyelinating Autoimmune Diseases, CNS" by people in Profiles.
-
Cortical and Subcortical Dysmetabolism Are Dynamic Markers of Clinical Disability and Course in Anti-LGI1 Encephalitis. Neurol Neuroimmunol Neuroinflamm. 2022 03; 9(2).
-
Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol. 2021 09; 20(9):762-772.
-
Evidence for and against subclinical disease activity and progressive disease in MOG antibody disease and neuromyelitis optica spectrum disorder. J Neuroimmunol. 2021 11 15; 360:577702.
-
A New England COVID-19 Registry of Patients With CNS Demyelinating Disease: A Pilot Analysis. Neurol Neuroimmunol Neuroinflamm. 2021 09; 8(5).
-
Progression pattern of neurological disability with respect to clinical attacks in anti-MOG antibody-associated disorders. J Neuroimmunol. 2021 02 15; 351:577467.
-
Editorial: Update on Translational Neuroimmunology - Research of ISNI 2018. Front Immunol. 2020; 11:2012.
-
Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study. Brain. 2020 05 01; 143(5):1431-1446.
-
MOG antibody-associated encephalomyelitis/encephalitis. Mult Scler. 2019 10; 25(11):1427-1433.
-
Radiological characteristics of myelin oligodendrocyte glycoprotein antibody disease. Mult Scler Relat Disord. 2019 Apr; 29:15-22.
-
An Overview of Autoimmune and Paraneoplastic Encephalitides. Semin Neurol. 2018 Jun; 38(3):330-343.